1、ATEA CorporatePresentationJanuary 2025DISCLAIMERSForward-Looking Statements This presentation contains“forward-looking statements”within the meaning of the Private Securities Litigation Reform Act of 1995.Forward-looking statements are neither historical facts nor assurances of future performance.In
2、stead,they are based on our current beliefs,expectations and assumptions regarding the future of our business,future plans and strategies,our clinical results and other future conditions including without limitation the future of the HCV landscape and related commercial market opportunities.All stat
3、ements other than statements of historical facts contained in this presentation are forward-looking statements,including statements by Atea Pharmaceuticals,Inc.(the“Company”)regarding future results of operations and financial position,including our anticipated cash runway;business strategy;current
4、and prospective product candidates;anticipated milestone events;potential benefits of our product candidates and market opportunity;clinical trials,including,without limitation,anticipated initiation,enrollment,regulatory submission and data readout timelines;preclinical activities;product approvals
5、;manufacturing availability;degree of market acceptance of any products that may be approved;research and development costs;current and prospective collaborations;and prospects and opportunities for investors.In some cases,you can identify forward-looking statements by terms such as“may,”“will,”“sho
6、uld,”“expects,”“plans,”“anticipates,”“could,”“intends,”“targets,”“projects,”“contemplates,”“believes,”“estimates,”“predicts,”“potential”or“continue”or the negative of these terms or other similar expressions.The information in this presentation,including without limitation the forward-looking statem